AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
NAPROXEN in Zimbabwe
3 products registered with MCAZ — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NAPROSCRIPT 500 TABLET; ORAL | 95/3.1/2992 | MULLER & PHIPPS | active | 31 Dec 2027 |
| NAPROSCRIPT-250 TABLET; ORAL | 95/3.1/2991 | MULLER & PHIPPS | active | 31 Dec 2027 |
| APO-NAPROXEN 250MG TABLET; ORAL | 90/3.1/2349 | APOTEX INC. | active | 31 Dec 2027 |
NAPROXEN — MCAZ Registration Details
MCAZ (Zimbabwe) has 3 registered products containing NAPROXEN, of which 3 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track NAPROXEN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.